A closer look at “FDA and CMS Race to Prevent Federal-State AI Regulation Clash in Healthcare”, exactly as the source publishes it. Federal health regulators are quietly working to defuse a looming conflict with states over oversight of artificial intelligence in clinical care. The Food and Drug Administration and the Centers for Medicare and Medicaid Services are engaging state officials and industry stakeholders to avoid a pat The Food and Drug Administration and the Centers for Medicare and Medicaid Services are engaging state officials and industry stakeholders to avoid a patchwork of rules that could stifle innovation, according to people familiar with the discussions.
States are increasingly exploring their own AI guardrails for medical devices and decision-support tools, raising concerns about overlapping and contradictory requirements. The FDA has long claimed primary authority over software as a medical device, while CMS oversees reimbursement and quality standards. This listing links straight to the original page, where the content is available in full.